Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1054 | 900 | 1110 | 1183 | 1458 | 2145 |
Fund Return | 5.45% | -10.03% | 11.01% | 5.77% | 7.83% | 7.93% |
Place in category | 147 | 176 | 158 | 38 | 70 | 56 |
% in Category | 78 | 96 | 87 | 19 | 40 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 740.1B | 27.63 | 10.36 | - | ||
Vanguard 500 Index Admiral | 577.55B | 28.02 | 11.39 | 13.31 | ||
Vanguard Total Stock Market Admiral | 421.1B | 27.60 | 10.34 | 12.84 | ||
Vanguard Total Intl Stock Index Inv | 206B | 7.87 | 2.85 | 4.88 | ||
Vanguard 500 Index Institutional Se | 204.82B | 28.06 | 11.42 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 37.96B | 5.49 | 5.82 | 7.98 | ||
Fidelity Select Health Care | 10.35B | 13.38 | 2.97 | 9.10 | ||
T. Rowe Price Health Sciences | 7.9B | 10.22 | 0.91 | 9.64 | ||
Fidelity Advisor Health Care A | 6.23B | 11.89 | 2.31 | 8.23 | ||
Fidelity Advisor Health Care C | 6.23B | 11.10 | 1.54 | 7.42 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.57 | 795.67 | -0.08% | |
UnitedHealth | US91324P1021 | 7.62 | 506.10 | -0.05% | |
AstraZeneca | GB0009895292 | 5.64 | 10,478.0 | +0.54% | |
Merck&Co | US58933Y1055 | 4.49 | 99.45 | +0.08% | |
Novo Nordisk B | DK0062498333 | 3.90 | 622.6 | +5.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review